MIT scientists debut AI model Boltz-2 that predicts drug binding affinity

A trio of young MIT scientists unveiled a new AI bio model on Friday that predicts binding affinities, a major challenge to discovering drugs that has previously evaded progress with other AI methods. Boltz-2 takes ...